ZHOU Zonglei, LI Kunpeng, LI Nannan, ZHOU Ruzhen. Age-period-cohort analysis of incidence and mortality trends of nasopharyngeal carcinoma in the Chinese population, 1994-2019[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(8): 869-876. doi: 10.16462/j.cnki.zhjbkz.2023.08.001
Citation:
ZHOU Zonglei, LI Kunpeng, LI Nannan, ZHOU Ruzhen. Age-period-cohort analysis of incidence and mortality trends of nasopharyngeal carcinoma in the Chinese population, 1994-2019[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(8): 869-876. doi: 10.16462/j.cnki.zhjbkz.2023.08.001
ZHOU Zonglei, LI Kunpeng, LI Nannan, ZHOU Ruzhen. Age-period-cohort analysis of incidence and mortality trends of nasopharyngeal carcinoma in the Chinese population, 1994-2019[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(8): 869-876. doi: 10.16462/j.cnki.zhjbkz.2023.08.001
Citation:
ZHOU Zonglei, LI Kunpeng, LI Nannan, ZHOU Ruzhen. Age-period-cohort analysis of incidence and mortality trends of nasopharyngeal carcinoma in the Chinese population, 1994-2019[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(8): 869-876. doi: 10.16462/j.cnki.zhjbkz.2023.08.001
Objective To understand the incidence and mortality trends of nasopharyngeal carcinoma among the Chinese population, and to evaluate the effect of age, period and birth cohort on the risk of nasopharyngeal carcinoma incidence and mortality.Methods Data on gender-specific incidence and mortality of nasopharyngeal carcinoma among the Chinese population between 1994 to 2014 were obtained through the Global Health Data Exchange Database. We described the temporal trend of nasopharyngeal carcinoma incidence and mortality, and the age effect, period effect, and cohort effect were estimated using an age-period-cohort (APC) model and intrinsic estimator method.Results The standardized incidence of nasopharyngeal carcinoma among Chinese male and female population increased from 4.16/100 000 and 2.26/100 000 in 1994 to 8.55/100 000 and 2.83/100 000 in 2019, while the standardized mortality of nasopharyngeal carcinoma decreased from 3.57/100 000 and 1.80/100 000 in 1994 to 2.20/100 000 and 0.72/100 000 in 2019. Results of APC analysis showed that during 1994-2019, age effect of nasopharyngeal carcinoma incidence in both Chinese male and female population increased first, then decreased and increased afterward with the increase of age [effect coefficient (male): -1.94-0.68 to 0.18-0.54, all P < 0.05; effect coefficient (female): -1.49-0.49 to 0.20-0.38, all P < 0.05]; period effect showed an increasing trend as year increased [effect coefficient (male): -0.44-0.53, all P < 0.05; effect coefficient (female): -0.12-0.24, all P < 0.05]; cohort effect decreased first, then increased and then decreased with the year of birth [effect coefficient (male): 0.82--0.36 to-0.05--0.36, all P < 0.05; effect coefficient (female): 0.63--0.17 to-0.01--0.57, all P < 0.05]. Age effect of nasopharyngeal carcinoma mortality in Chinese population exhibited an upward trend with the increase of age [effect coefficient (male): -2.08-1.04, all P < 0.05; effect coefficient (female): -1.75-1.08, all P < 0.05]; cohort effect of nasopharyngeal carcinoma mortality among Chinese male population decreased with year of birth (effect coefficient: 0.95--0.89, P < 0.05). However, significant period effect of nasopharyngeal carcinoma mortality in the whole population and cohort effect of nasopharyngeal carcinoma mortality among Chinese female population were not observed.Conclusions Age effect exerts impacts on the risk of nasopharyngeal carcinoma incidence in both Chinese male and female population to varying degrees. The risk of nasopharyngeal carcinoma mortality among Chinese male population is affected by age effect and cohort effect, while the risk of nasopharyngeal carcinoma mortality in Chinese female population is only affected by age effect. Health education and screening for nasopharyngeal cancer are suggested to be strengthened for individuals aged over 40 years, especially for males to reduce the risk of nasopharyngeal carcinoma incidence and mortality.
Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192): 64-80. DOI: 10.1016/S0140-6736(19)30956-0.
[2]
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108. DOI: 10.3322/caac.21262.
[3]
Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(10): 1765-1777. DOI: 10.1158/1055-9965.EPI-06-0353.
[4]
Yin DP, Zheng YF, Sun P, et al. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma[J]. Cell Death Dis, 2022, 13(3): 210. DOI: 10.1038/s41419-022-04637-8.
[5]
Bai R, Sun J, Xu Y, et al. Incidence and mortality trends of nasopharynx cancer from 1990 to 2019 in China: an age-period-cohort analysis[J]. BMC Public Health, 2022, 22(1): 1351. DOI: 10.1186/s12889-022-13688-7.
[6]
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1736-1788. DOI: 10.1016/S0140-6736(18)32203-7.
[7]
Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement[J]. Lancet, 2016, 388(10062): e19-e23. DOI: 10.1016/S0140-6736(16)30388-9.Z.
Lei L, Shang QG, Liu WG, et al. Incidences and epidemiologic trends of nasopharyngeal cancer in Shenzhen, 2001-2015[J]. Chin J Cancer Prev Treat, 2019, 26(20): 1499-1503. DOI: 10.16073/j.cnki.cjcpt.2019.20.02.
Zhang XP, Li QJ, Bian F, et al. Analysis of survival rates and prognostic factors in 110 patients with nasopharyngeal carcinoma[J]. Chin J Otorhinolaryngol Skull Base Surg, 2014, 20(6): 507-511. DOI: 10.11798/j.issn.1007-1520.201406010.
[10]
Wu CY, Lin YH, Lo WC, et al. Nutritional status at diagnosis is prognostic for pharyngeal cancer patients: a retrospective study[J]. Eur Arch Otorhinolaryngol, 2022, 279(7): 3671-3678. DOI: 10.1007/s00405-021-07222-5.
[11]
Yang L, Xue Y, Wei Z, et al. Local radiotherapy versus nonradiotherapy to distant lesions for metastatic nasopharyngeal carcinoma: Retrospective cohort study[J]. Head Neck, 2022, 44(3): 615-623. DOI: 10.1002/hed.26953.
[12]
Xie SH, Yu IT, Tse LA, et al. Occupational risk factors for nasopharyngeal carcinoma in Hong Kong Chinese: a case-referent study[J]. Int Arch Occup Environ Health, 2017, 90(5): 443-449. DOI: 10.1007/s00420-017-1212-4.
[13]
曹方政. 医疗保险制度的中日比较研究[D]. 长春: 吉林大学, 2017.
Cao FZ. A Comparative Study on the Medical Insurance Systems in China and Japan[D]. Changchun: Jilin University, 2017.